RET and hereditary pheochromocytoma-paraganglioma: The FMTC constitutes a variant of the Multiple Endocrine Neoplasia type 2A (MEN2A) phenotype, characterized together with MEN2B variant phenotype, by an increased risk to develop pheochromocytoma [65].